Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2.

Abstract:

:Collagen sponge disks (6 mm diameter, 1 mm thickness) were impregnated with recombinant human bone morphogenetic protein-2 (rhBMP-2) (5 microg/disk) and implanted onto the back muscles of mice. Ten or 20 mg/kg per day of Rolipram, a selective inhibitory agent to phosphodiesterase type 4 (PDE-4), or vehicle, was injected subcutaneously into the host mice for 3 weeks. After treatment, rhBMP-2-induced ectopic ossicles were harvested and examined by radiographic and histologic methods to determine the size, bone quality, and mineral content of the ossicles. The ossicles from a group treated with 20 mg/kg per day Rolipram were significantly larger in size and higher in bone mineral density (BMD) and bone mineral content (BMC) than the control samples. No significant differences were noted in mice treated with 10 mg/kg per day of Rolipram. Histologically, ossicles from the high-dose (20 mg/kg per day) Rolipram-treated group showed densely packed, thicker trabeculae when compared with those from the control group. These experimental results indicate that the PDE-4 inhibitor, Rolipram, may enhance the bone-inducing capacity of BMP-2 in mesenchymal cells. This in turn may result in increased responsiveness to BMP-2 and point to a potential use of PDE-4 inhibitors for the promotion of rhBMP-dependent bone repair.

journal_name

Bone

journal_title

Bone

authors

Horiuchi H,Saito N,Kinoshita T,Wakabayashi S,Yotsumoto N,Takaoka K

doi

10.1016/s8756-3282(02)00681-6

subject

Has Abstract

pub_date

2002-04-01 00:00:00

pages

589-93

issue

4

eissn

8756-3282

issn

1873-2763

pii

S8756328202006816

journal_volume

30

pub_type

杂志文章

相关文献

BONE文献大全
  • The elementary fusion modalities of osteoclasts.

    abstract::The last step of the osteoclast differentiation process is cell fusion. Most efforts to understand the fusion mechanism have focused on the identification of molecules involved in the fusion process. Surprisingly, the basic fusion modalities, which are well known for fusion of other cell types, are not known for the o...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.12.010

    authors: Søe K,Hobolt-Pedersen AS,Delaisse JM

    更新日期:2015-04-01 00:00:00

  • Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions.

    abstract::Recent studies have identified that Interleukin (IL)-23/IL-17 axis plays crucial role in pathogenesis of inflammation and bone destruction. IL-23 is thought to promote joint destruction in arthritis by stimulating Th17 cells. IL-23 directly mediates bone loss by inducing osteoclastogenesis and receptor activator of ka...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.01.027

    authors: Shukla P,Mansoori MN,Singh D

    更新日期:2018-05-01 00:00:00

  • Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.

    abstract::Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation. However, the molecular mechanism underlying the inhibition of osteoclast differentiation by ginsenoside Rh2 remains poorly understood. In the present study, it was ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.03.022

    authors: He L,Lee J,Jang JH,Lee SH,Nan MH,Oh BC,Lee SG,Kim HH,Soung NK,Ahn JS,Kim BY

    更新日期:2012-06-01 00:00:00

  • Parathyroid hormone regulates the expression of the nuclear mitotic apparatus protein in the osteoblast-like cells, ROS 17/2.8.

    abstract::The parathyroid hormone (PTH) signaling pathways that effect changes in osteoblast gene expression also alter the organization of the cytoskeletal proteins. PTH regulates the expression of nucleoskeletal proteins, such as nuclear mitotic apparatus protein (NuMA) and topoisomerase II-alpha. NuMA is a structural compone...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(97)00300-1

    authors: Torrungruang K,Feister H,Swartz D,Hancock EB,Hock J,Bidwell JP

    更新日期:1998-04-01 00:00:00

  • Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.

    abstract::Treatment with parathyroid hormone 1-84 (PTH) or teriparatide increases osteonal remodeling and decreases bone mineral density (BMD) at cortical (Ct) bone sites but may also increase bone size. Decreases in BMD and increases in size exert opposing effects on bone strength. In adult ovariectomized (OVX) rhesus monkeys,...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2007.04.197

    authors: Fox J,Miller MA,Newman MK,Recker RR,Turner CH,Smith SY

    更新日期:2007-09-01 00:00:00

  • Age at menarche and osteoporosis: A Mendelian randomization study.

    abstract:PURPOSE:Traditional epidemiological studies suggest that there is an association between age at menarche (years) (AAM) and bone mineral density (BMD) at the sites of the femoral neck and lumbar spine (FNK and LS BMD), indicating a potentially important relationship between AAM and the development of osteoporosis (OP). ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.09.015

    authors: Zhang Q,Greenbaum J,Zhang WD,Sun CQ,Deng HW

    更新日期:2018-12-01 00:00:00

  • Determinants of ovine compact bone viscoelastic properties: effects of architecture, mineralization, and remodeling.

    abstract::Significant decreases in ovine compact bone viscoelastic properties (specifically, stress-rate sensitivity, and damping efficiency) are associated with three years of ovariectomy and are particularly evident at higher frequencies [Proc. Orthop. Res. Soc. 27 (2002) 89]. It is unclear what materials or architectural fea...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2004.04.006

    authors: Les CM,Spence CA,Vance JL,Christopherson GT,Patel B,Turner AS,Divine GW,Fyhrie DP

    更新日期:2004-09-01 00:00:00

  • Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.

    abstract::Embryonic/neonatal bones in culture are commonly used for the study of osteoclastic resorption in vitro. For this purpose, the release of 45calcium (45Ca) from prelabeled bones is measured as an index of resorption. We studied 45Ca release from two types of long bone explants after different preparation methods: 17-da...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00135-z

    authors: van Beek E,Oostendorp-van de Ruit M,van der Wee-Pals L,Bloys H,van de Bent C,Papapoulos S,Löwik C

    更新日期:1995-07-01 00:00:00

  • Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

    abstract::We examined the mode of action of bisphosphonates on osteoclastic cell recruitment using mouse marrow cultures with or without osteoblastic cells. Tartrate-resistant acid phosphatase-positive multinucleated cells [TRAP(+)MNC] formed in cultures were determined to be osteoclastic cells. In marrow cultures, TRAP(+) MNC ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00426-2

    authors: Nishikawa M,Akatsu T,Katayama Y,Yasutomo Y,Kado S,Kugal N,Yamamoto M,Nagata N

    更新日期:1996-01-01 00:00:00

  • Potential predictive factors of osteoporosis in HIV-positive subjects.

    abstract::Recent reports showed a high frequency of osteopenia/osteoporosis in HIV-infected subjects. Mechanism on the basis of this alteration is still unclear, as the direct effect of virus or of antiretroviral drugs. One hundred sixty-one consecutive HIV-infected outpatients aged 30-50 years, both naive and HAART-treated for...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.11.001

    authors: Fausto A,Bongiovanni M,Cicconi P,Menicagli L,Ligabò EV,Melzi S,Bini T,Sardanelli F,Cornalba G,Monforte Ad

    更新日期:2006-06-01 00:00:00

  • Teriparatide attenuates scarring around murine cranial bone allograft via modulation of angiogenesis.

    abstract::Nearly all bone fractures in humans can deteriorate into a non-union fracture, often due to formation of fibrotic tissue. Cranial allogeneic bone grafts present a striking example: although seemingly attractive for craniofacial reconstructions, they often fail due to fibrosis at the host-graft junction, which physical...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.01.020

    authors: Cohn Yakubovich D,Eliav U,Yalon E,Schary Y,Sheyn D,Cook-Wiens G,Sun S,McKenna CE,Lev S,Binshtok AM,Pelled G,Navon G,Gazit D,Gazit Z

    更新日期:2017-04-01 00:00:00

  • The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: A cohort study.

    abstract:PURPOSE:To evaluate the effects of different definitions of glucocorticoid (GC) exposure on the magnitude and pattern of fracture risk using the same dataset. METHODS:Data from patients with rheumatoid arthritis (RA) were extracted from the Clinical Practice Research Datalink, a primary care database with electronic h...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2018.09.004

    authors: Robinson DE,van Staa TP,Dennison EM,Cooper C,Dixon WG

    更新日期:2018-12-01 00:00:00

  • Sex-specific compromised bone healing in female rats might be associated with a decrease in mesenchymal stem cell quantity.

    abstract:INTRODUCTION:The clinically known importance of patient sex as a major risk factor for compromised bone healing is poorly reflected in animal models. Consequently, the underlying cellular mechanisms remain elusive. Because mesenchymal stem cells (MSCs) are postulated to regulate tissue regeneration and give rise to ess...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.08.005

    authors: Strube P,Mehta M,Baerenwaldt A,Trippens J,Wilson CJ,Ode A,Perka C,Duda GN,Kasper G

    更新日期:2009-12-01 00:00:00

  • Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.

    abstract::Although basic fibroblast growth factor (bFGF) is a potent stimulator of bone formation when administered intravenously, less is known regarding the effects of this peptide on bone following subcutaneous (s.c.) administration. In addition, it is unknown whether coadministration of estrogen enhances the bone response t...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(03)00118-2

    authors: Iwaniec UT,Magee KA,Mitova-Caneva NG,Wronski TJ

    更新日期:2003-09-01 00:00:00

  • Immobilization-induced osteolysis and recovery in neuropathic foot impairments.

    abstract:BACKGROUND:Neuropathic foot impairments treated with immobilization and off-loading result in osteolysis. In order to prescribe and optimize rehabilitation programs after immobilization we need to understand the magnitude of pedal osteolysis after immobilization and the time course for recovery. OBJECTIVE:To determine...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.09.009

    authors: Sinacore DR,Hastings MK,Bohnert KL,Strube MJ,Gutekunst DJ,Johnson JE

    更新日期:2017-12-01 00:00:00

  • Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice.

    abstract::X-linked hypophosphatemia (XLH) is characterized by rickets and osteomalacia and arises from mutations in the Phex and PHEX genes in mice (Hyp) and humans, respectively. The present study was undertaken to examine the effect of gene dose on the skeletal phenotype using a histomorphometric approach. Metrical traits (ve...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2003.09.004

    authors: Qiu ZQ,Travers R,Rauch F,Glorieux FH,Scriver CR,Tenenhouse HS

    更新日期:2004-01-01 00:00:00

  • Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation.

    abstract::Mechanical signal transduction in bone tissue begins with load-induced activation of several cellular pathways in the osteocyte population. A key pathway that participates in mechanotransduction is Wnt/Lrp5 signaling. A putative downstream mediator of activated Lrp5 is the nucleocytoplasmic shuttling protein β-catenin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.04.028

    authors: Kang KS,Hong JM,Robling AG

    更新日期:2016-07-01 00:00:00

  • Co-deteriorations of anisotropic extracellular matrix arrangement and intrinsic mechanical property in c-src deficient osteopetrotic mouse femur.

    abstract::Osteopetrotic bone shows dissociation between bone mineral density (BMD) and bone strength. In this study, volumetric BMD; preferential orientation of the extracellular matrix (ECM), which is composed of collagen fibers and apatite crystals as bone material quality; and mechanical properties of the src-/- osteopetroti...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.06.023

    authors: Ishimoto T,Sato B,Lee JW,Nakano T

    更新日期:2017-10-01 00:00:00

  • The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women.

    abstract::To determine the ability of bone turnover to predict the response in bone mass during treatment with Tibolone, two biochemical markers of bone metabolism were evaluated [CrossLaps corrected for urinary creatinine (CrossLaps/Cr.) and serum osteocalcin measured in a newly developed assay (N-Mid)]. Data from a 2-year dou...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s8756-3282(96)00335-3

    authors: Bjarnason NH,Bjarnason K,Hassager C,Christiansen C

    更新日期:1997-02-01 00:00:00

  • Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS).

    abstract:INTRODUCTION AND HYPOTHESIS:Diagnosis of prevalent osteoporotic vertebral fracture is complicated by normal or developmental variation in vertebral shape or size and non-osteoporotic deformities that appear to have 'reduced' height. Using our visual approach, the algorithm-based qualitative method (ABQ) a vertebra with...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.bone.2007.03.015

    authors: Ferrar L,Jiang G,Armbrecht G,Reid DM,Roux C,Glüer CC,Felsenberg D,Eastell R

    更新日期:2007-07-01 00:00:00

  • Circulating endothelial/skeletal progenitor cells for bone regeneration and healing.

    abstract::An emerging strategy in the regeneration and repair of bone is to use stem cells, including bone marrow mesenchymal stem cells, which are the most investigated and reliable source for tissue engineering, as well as circulating skeletal stem/progenitor cells, which are receiving abundant attention in regenerative medic...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2008.05.001

    authors: Matsumoto T,Kuroda R,Mifune Y,Kawamoto A,Shoji T,Miwa M,Asahara T,Kurosaka M

    更新日期:2008-09-01 00:00:00

  • A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).

    abstract:BACKGROUND:Fibrodysplasia ossificans progressiva (FOP) is a catastrophic genetic disorder of progressive heterotopic ossification (HO). Assessment of functional mobility in FOP will be essential to support clinical trials of investigational agents. RESULTS:Of necessity, we developed a simple, rapidly-administered, cum...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.04.015

    authors: Kaplan FS,Al Mukaddam M,Pignolo RJ

    更新日期:2017-08-01 00:00:00

  • A xenograft model to evaluate the bone forming effects of sclerostin antibody in human bone derived from pediatric osteogenesis imperfecta patients.

    abstract::Osteogenesis imperfecta (OI) is a rare and severe skeletal dysplasia marked by low bone mass and poor bone quality which is especially burdensome during childhood. Since clinical trials for pediatric OI are difficult, there is a widespread reliance on genetically modified murine models to understand the skeletal effec...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115118

    authors: Surowiec RK,Battle LF,Ward FS,Schlecht SH,Khoury BM,Robbins C,Wojtys EM,Caird MS,Kozloff KM

    更新日期:2020-01-01 00:00:00

  • The clover and heart signs in vertebral scintigraphic images are highly specific of Paget's disease of bone.

    abstract:BACKGROUND:Bone scintigraphy used as a diagnostic technique frequently yields non-specific intense uptake by vertebrae. Bone biopsy may therefore be required to establish a diagnosis in cases of Paget's disease of bone. The aim of the study was to ascertain the sensitivity and specificity of two new images-heart sign a...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2003.10.014

    authors: Rotés-Sala D,Monfort J,Solano A,Miralles E,Vila J,Carbonell J

    更新日期:2004-04-01 00:00:00

  • Bone structure in two adult subjects with impaired minor spliceosome function resulting from RNU4ATAC mutations causing microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1).

    abstract::Microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1), or Taybi-Linder syndrome is characterized by distinctive skeletal dysplasia, severe intrauterine and postnatal growth retardation, microcephaly, dysmorphic features, and neurological malformations. It is an autosomal recessive disorder caused by homozyg...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.08.023

    authors: Krøigård AB,Frost M,Larsen MJ,Ousager LB,Frederiksen AL

    更新日期:2016-11-01 00:00:00

  • The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering.

    abstract::Bone is a nanocomposite consisting of two main components, nano-hydroxyapatite (n-HA) and Type I collagen (Col). The aim is to exploit the nano-scale functional and material characteristics of natural bone in order to modulate cellular functions for optimal bone repair in bone graft systems. Here, we present an effect...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.03.674

    authors: Ngiam M,Liao S,Patil AJ,Cheng Z,Chan CK,Ramakrishna S

    更新日期:2009-07-01 00:00:00

  • Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom.

    abstract::This cohort study of postmenopausal women in the United Kingdom aged ≥50years determined the incremental cost of health care and clinical outcomes in the 12months following incident, selected fractures (non-vertebral non-hip [NVNHF], vertebral [VF] and multiple [MF]). Incremental costs and outcomes of the fracture coh...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.05.020

    authors: Gutiérrez L,Roskell N,Castellsague J,Beard S,Rycroft C,Abeysinghe S,Shannon P,Gitlin M,Robbins S

    更新日期:2012-09-01 00:00:00

  • Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein.

    abstract::Bone sialoprotein (BSP) is a multifunctional extracellular matrix protein found in mineralized tissues, including bone, cartilage, tooth root cementum (both acellular and cellular types), and dentin. In order to define the role BSP plays in the process of biomineralization of these tissues, we analyzed cementogenesis,...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2015.05.007

    authors: Foster BL,Ao M,Willoughby C,Soenjaya Y,Holm E,Lukashova L,Tran AB,Wimer HF,Zerfas PM,Nociti FH Jr,Kantovitz KR,Quan BD,Sone ED,Goldberg HA,Somerman MJ

    更新日期:2015-09-01 00:00:00

  • Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.

    abstract::The cathepsin K (CatK) inhibitor odanacatib (ODN) is currently being developed for the treatment of osteoporosis. In clinical trials, efficacy and resolution of effect of ODN treatment on bone turnover biomarkers and accrued bone mass have been demonstrated. Here, we examine the effects of continuing treatment and dis...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.07.013

    authors: Zhuo Y,Gauthier JY,Black WC,Percival MD,Duong LT

    更新日期:2014-10-01 00:00:00

  • Development of a molecular test of Paget's disease of bone.

    abstract::Depending on populations, 15 to 40% of patients have a familial form of Paget's disease of bone (PDB), which is transmitted in an autosomal-dominant mode of inheritance with incomplete penetrance. To date, only SQSTM1 gene mutations have been linked to the disease. Several single nucleotide polymorphisms (SNPs) have b...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2016.01.007

    authors: Guay-Bélanger S,Simonyan D,Bureau A,Gagnon E,Albert C,Morissette J,Siris ES,Orcel P,Brown JP,Michou L

    更新日期:2016-03-01 00:00:00